Stomach cancer is the fifth most common cancer worldwide, often undiagnosed until advanced stages. Recognising persistent ...

New research uncovers how regular salt consumption could elevate the risk of gastric cancer. Is your salt shaker to blame?

The following is a summary of “Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic ...

Claire Boulton, who has Irritable Bowel Syndrome (IBS), felt 'fobbed off' for years until she pushed to have hospital tests ...

Adding intraperitoneal paclitaxel to intravenous paclitaxel and oral S-1 improved survival in patients with gastric cancer and peritoneal metastasis.

A genetic test revealing a hereditary cancer risk empowered Jason McClure, a young father, to undergo a life-saving total gastrectomy, inspiring others to prioritize health awareness.

Gastric cancer is often diagnosed in the advanced or metastatic stage, and has a lamentable five-year relative survival rate of only around 6%, as patients have very limited treatment options.

Researchers compare nivolumab as monotherapy or in combination with chemotherapy vs conventional treatment on overall survival and progression-free survival in patients with advanced unresectable ...

Gastric cancer diagnostics companies are Abbott, BD, Bio-Rad Laboratories, Roche, Siemens Healthineers, Thermo Fisher Scientific, Pillar Biosciences, ETC ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Here are the most anticipated abstracts to keep an eye on going into the 2025 ASCO Gastrointestinal Cancers Symposium.